Anti-IL-27 antibodies and uses thereof
Grant
US12577299B2
Kind: B2
Mar 17, 2026
Assignee
SURFACE ONCOLOGY, LLC
Inventors
Alison O'Neill, Lauren Harshman, Jonathan Hill, Jou-Ku Chung, Kerry White, Robert Ross, Benjamin Lee
Abstract
The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof at a dose of at least about 0.003 mg/kg to at least about 20 mg/kg.
CPC Classifications
A61P 35/00
A61K 2039/505
A61K 2039/545
C07K 16/244
C07K 2317/565
C07K 2317/76
C07K 2317/92
Filing Date
2022-05-06
Application No.
17738927
Claims
22